Bio-Connect
Lane 1: DU145 cell lysates probed with CTAG2 Polyclonal Antibody, Unconjugated (bs-6807R) at 1:300 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.
Lane 1: DU145 cell lysates probed with CTAG2 Polyclonal Antibody, Unconjugated (bs-6807R) at 1:300 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.
Lane 1: DU145 cell lysates probed with CTAG2 Polyclonal Antibody, Unconjugated (bs-6807R) at 1:300 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.

CTAG2 Polyclonal Antibody

BS-6807R
Bioss
ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetCTAG2
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Bioss
  • Product Name
    CTAG2 Polyclonal Antibody
  • Delivery Days Customer
    16
  • Applications
    Western Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Applications Supplier
    WB(1:300-5000), ELISA(1:500-1000), IHC-P(1:200-400)
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 ug/ul
  • Conjugate
    Unconjugated
  • Gene ID30848
  • Target name
    CTAG2
  • Target description
    cancer/testis antigen 2
  • Target synonyms
    CAMEL, CT2, CT6.2, CT6.2a, CT6.2b, ESO2, LAGE-1, LAGE2B, cancer/testis antigen 2, CTL-recognized antigen on melanoma, LAGE-1a protein, autoimmunogenic cancer/testis antigen NY-ESO-2, cancer/testis antigen 6.2, cancer/testis antigen family 6, member 2a, cancer/testis antigen family 6, member 2b, l antigen family member 1
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDO75638
  • Protein Name
    Cancer/testis antigen 2
  • Reactivity
    Human
  • Storage Instruction
    -20°C
  • UNSPSC
    41116161

References

  • Identification of cancer/testis antigen 2 gene as a potential hepatocellular carcinoma therapeutic target by hub gene screening with topological analysis. Liu J et al., 2019 Nov, Oncol Lett
    Read this paper